Synopsis
Synopsis
0
VMF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Apo Pravastatin
2. Apo-pravastatin
3. Bristacol
4. Cs 514
5. Cs-514
6. Cs514
7. Elisor
8. Eptastatin
9. Lin Pravastatin
10. Lin-pravastatin
11. Lipemol
12. Liplat
13. Lipostat
14. Mevalotin
15. Nu Pravastatin
16. Nu-pravastatin
17. Prareduct
18. Pravachol
19. Pravacol
20. Pravasin
21. Pravastatin
22. Pravastatin Monosodium Salt, (6 Beta)-isomer
23. Pravastatin Sodium Salt
24. Pravastatin Tert Octylamine Salt
25. Pravastatin Tert-octylamine Salt
26. Pravastatin, (6 Beta)-isomer
27. Rms 431
28. Rms-431
29. Rms431
30. Selektine
31. Sodium Salt, Pravastatin
32. Sq 31,000
33. Sq 31000
34. Sq-31,000
35. Sq-31000
36. Sq31,000
37. Sq31000
38. Vasten
1. 81131-70-6
2. Pravachol
3. Mevalotin
4. Selektine
5. Elisor
6. Pravaselect
7. Lipostat
8. Eptastatin Sodium
9. Cs-514
10. Pravastatin Sodium Salt
11. Pravastatin (sodium)
12. Dehypotin Protect
13. Sq-31000
14. Sq-31,000
15. Chebi:8361
16. Bristacol
17. Lipemol
18. Prareduct
19. Pravacol
20. Pravasin
21. 3m8608uq61
22. Nsc-759253
23. Sodium;(3r,5r)-7-[(1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
24. Aplactin
25. Lipidal
26. Liprevil
27. Pralidon
28. Pravasine
29. Sanaprav
30. Selipran
31. Vasen
32. Epastatin Sodium
33. Dsstox_cid_27525
34. Dsstox_rid_82395
35. Dsstox_gsid_47525
36. Liplat
37. Vasten
38. Pravastatin, Sodium Salt
39. (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-(((s)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic Acid, Sodium Salt
40. Cas-81131-70-6
41. Pravastatin Natrium Mayrho Fer
42. Sq 31000
43. 3-beta-hydroxycompactin Sodium Salt
44. Drg-0319
45. Chembl690
46. Unii-3m8608uq61
47. Cres Pravastatin
48. Pravachol (tn)
49. Ncgc00095183-01
50. Pravastatin Sodium [usan:usp:jan]
51. Mfcd00887601
52. Pravastatinsodium,(s)
53. Cs-514 Sodium
54. Pravastatin Sodium- Bio-x
55. Schembl3013
56. Sodium (+)-(betar,deltar,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2s)-2-methylbutyrate)
57. Pravastatin Sodium [mi]
58. Dtxsid6047525
59. Pravastatin Sodium [jan]
60. Hy-b0165a
61. Pravastatin Sodium (jp17/usp)
62. Pravastatin Sodium [usan]
63. Hms2051p05
64. Hms3268l20
65. Hms3413e20
66. Pravastatin Sodium [vandf]
67. Hexahydronaphthalen-1-yl)heptanoate
68. Pravastatin Sodium [mart.]
69. Amy40517
70. Pravastatin Sodium [usp-rs]
71. Pravastatin Sodium [who-dd]
72. Tox21_111474
73. Tox21_300270
74. S3036
75. Akos015896504
76. Akos015964902
77. Ccg-100926
78. Cs-2003
79. Nc00176
80. Nsc 759253
81. Pravastatin Sodium [orange Book]
82. Ncgc00092370-01
83. Ncgc00254232-01
84. Pravastatin Sodium [ep Monograph]
85. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, Monosodium Salt, (1s-(1-alpha(beta-s*,delta-s*),2-alpha,6-alpha,8-beta(r*),8a-alpha))-
86. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, Monosodium Salt, (1s-(1alpha(betas*,deltas*),2alpha,6alpha,8beta(r*),8aalpha))-
87. Bp164292
88. Pravastatin Sodium [usp Monograph]
89. P1796
90. D00893
91. Pravigard Pac Component Pravastatin Sodium
92. Pravastatin Sodium Component Of Pravigard Pac
93. Q27108059
94. Pravastatin Sodium Salt Hydrate, >=98% (hplc), Powder
95. 2-methyl-8-((s)-2-methylbutanoyloxy)-1,2,6,7,8,8a-
96. Sodium (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-
97. (?r,?r,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2s)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic Acid Monosodium Salt
98. (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-(((s)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoicacid,sodiumsalt
99. 1-naphthaleneheptanoic Acid, 1,2,6,7,8,8a-hexahydro-.beta.,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, Monosodium Salt, (1s-(1.alpha.(.beta.s*,ds*),2.alpha.,6.alpha.,8.beta.(r*),8a.alpha.))-
100. Sodium (+)-(.beta.r,dr,1s,2s,6s,8s,8ar)-1,2,6,7,8,8a-hexahydro-.beta.,d,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2s)-2-methylbutyrate)
101. Sodium (3r,5r)-3,5-dihydroxy-7-((1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-((s)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
102. Sodium (3r,5r)-3,5-dihydroxy-7-[(1s,2s,6s,8s,8ar)-6-hydroxy-2-methyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
Molecular Weight | 446.5 g/mol |
---|---|
Molecular Formula | C23H35NaO7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 11 |
Exact Mass | 446.22804773 g/mol |
Monoisotopic Mass | 446.22804773 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 662 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Pravachol |
PubMed Health | Pravastatin (By mouth) |
Drug Classes | Antihyperlipidemic |
Drug Label | PRAVACHOL (pravastatin sodium) is one of a class of lipid-lowering compounds, the statins, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of HMG-CoA reductase, the enzyme catalyzing the early rate-limiting step in ch... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
2 of 4 | |
---|---|
Drug Name | Pravastatin sodium |
Drug Label | Pravastatin sodium tablets are one of a class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase,... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Teva; Lupin Pharms; Apotex; Sandoz; Cipla; Watson Labs; Glenmark Generics; Teva Pharms; Pliva Hrvatska Doo; Zydus Pharms Usa; Dr Reddys Labs; Mylan |
3 of 4 | |
---|---|
Drug Name | Pravachol |
PubMed Health | Pravastatin (By mouth) |
Drug Classes | Antihyperlipidemic |
Drug Label | PRAVACHOL (pravastatin sodium) is one of a class of lipid-lowering compounds, the statins, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of HMG-CoA reductase, the enzyme catalyzing the early rate-limiting step in ch... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Prescription |
Company | Bristol Myers Squibb |
4 of 4 | |
---|---|
Drug Name | Pravastatin sodium |
Drug Label | Pravastatin sodium tablets are one of a class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase,... |
Active Ingredient | Pravastatin sodium |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 10mg; 80mg; 40mg; 20mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Teva; Lupin Pharms; Apotex; Sandoz; Cipla; Watson Labs; Glenmark Generics; Teva Pharms; Pliva Hrvatska Doo; Zydus Pharms Usa; Dr Reddys Labs; Mylan |
Anticholesteremic Agents
Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14235
Submission : 1999-06-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17023
Submission : 2003-12-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16048
Submission : 2002-07-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5968
Submission : 1985-08-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7568
Submission : 1988-07-11
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16975
Submission : 2003-11-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16204
Submission : 2002-10-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15922
Submission : 2002-04-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16031
Submission : 2002-06-26
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-24
Pay. Date : 2012-11-13
DMF Number : 14729
Submission : 2000-02-25
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?